Cargando…
Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats
Intestinal disorders often co-occur with inflammation and dysmotility. However, drugs which simultaneously improve intestinal inflammation and co-occurring dysmotility are rarely reported. Atractylodin, a widely used herbal medicine, is used to treat digestive disorders. The present study was design...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214900/ https://www.ncbi.nlm.nih.gov/pubmed/28066135 http://dx.doi.org/10.4196/kjpp.2017.21.1.1 |
_version_ | 1782491688753692672 |
---|---|
author | Yu, Changchun Xiong, Yongjian Chen, Dapeng Li, Yanli Xu, Bin Lin, Yuan Tang, Zeyao Jiang, Chunling Wang, Li |
author_facet | Yu, Changchun Xiong, Yongjian Chen, Dapeng Li, Yanli Xu, Bin Lin, Yuan Tang, Zeyao Jiang, Chunling Wang, Li |
author_sort | Yu, Changchun |
collection | PubMed |
description | Intestinal disorders often co-occur with inflammation and dysmotility. However, drugs which simultaneously improve intestinal inflammation and co-occurring dysmotility are rarely reported. Atractylodin, a widely used herbal medicine, is used to treat digestive disorders. The present study was designed to characterize the effects of atractylodin on amelioration of both jejunal inflammation and the co-occurring dysmotility in both constipation-prominent (CP) and diarrhea-prominent (DP) rats. The results indicated that atractylodin reduced proinflammatory cytokines TNF-α, IL-1β, and IL-6 in the plasma and inhibited the expression of inflammatory mediators iNOS and NF-kappa B in jejunal segments in both CP and DP rats. The results indicated that atractylodin exerted stimulatory effects and inhibitory effects on the contractility of jejunal segments isolated from CP and DP rats respectively, showing a contractile-state-dependent regulation. Atractylodin-induced contractile-state-dependent regulation was also observed by using rat jejunal segments in low and high contractile states respectively (5 pairs of low/high contractile states). Atractylodin up-regulated the decreased phosphorylation of 20 kDa myosin light chain, protein contents of myosin light chain kinase (MLCK), and MLCK mRNA expression in jejunal segments of CP rats and down-regulated those increased parameters in DP rats. Taken together, atractylodin alleviated rat jejunal inflammation and exerted contractile-state-dependent regulation on the contractility of jejunal segments isolated from CP and DP rats respectively, suggesting the potential clinical implication for ameliorating intestinal inflammation and co-occurring dysmotility. |
format | Online Article Text |
id | pubmed-5214900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Physiological Society and The Korean Society of Pharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-52149002017-01-06 Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats Yu, Changchun Xiong, Yongjian Chen, Dapeng Li, Yanli Xu, Bin Lin, Yuan Tang, Zeyao Jiang, Chunling Wang, Li Korean J Physiol Pharmacol Original Article Intestinal disorders often co-occur with inflammation and dysmotility. However, drugs which simultaneously improve intestinal inflammation and co-occurring dysmotility are rarely reported. Atractylodin, a widely used herbal medicine, is used to treat digestive disorders. The present study was designed to characterize the effects of atractylodin on amelioration of both jejunal inflammation and the co-occurring dysmotility in both constipation-prominent (CP) and diarrhea-prominent (DP) rats. The results indicated that atractylodin reduced proinflammatory cytokines TNF-α, IL-1β, and IL-6 in the plasma and inhibited the expression of inflammatory mediators iNOS and NF-kappa B in jejunal segments in both CP and DP rats. The results indicated that atractylodin exerted stimulatory effects and inhibitory effects on the contractility of jejunal segments isolated from CP and DP rats respectively, showing a contractile-state-dependent regulation. Atractylodin-induced contractile-state-dependent regulation was also observed by using rat jejunal segments in low and high contractile states respectively (5 pairs of low/high contractile states). Atractylodin up-regulated the decreased phosphorylation of 20 kDa myosin light chain, protein contents of myosin light chain kinase (MLCK), and MLCK mRNA expression in jejunal segments of CP rats and down-regulated those increased parameters in DP rats. Taken together, atractylodin alleviated rat jejunal inflammation and exerted contractile-state-dependent regulation on the contractility of jejunal segments isolated from CP and DP rats respectively, suggesting the potential clinical implication for ameliorating intestinal inflammation and co-occurring dysmotility. The Korean Physiological Society and The Korean Society of Pharmacology 2017-01 2016-12-21 /pmc/articles/PMC5214900/ /pubmed/28066135 http://dx.doi.org/10.4196/kjpp.2017.21.1.1 Text en Copyright © Korean J Physiol Pharmacol http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yu, Changchun Xiong, Yongjian Chen, Dapeng Li, Yanli Xu, Bin Lin, Yuan Tang, Zeyao Jiang, Chunling Wang, Li Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
title | Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
title_full | Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
title_fullStr | Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
title_full_unstemmed | Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
title_short | Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
title_sort | ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214900/ https://www.ncbi.nlm.nih.gov/pubmed/28066135 http://dx.doi.org/10.4196/kjpp.2017.21.1.1 |
work_keys_str_mv | AT yuchangchun ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT xiongyongjian ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT chendapeng ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT liyanli ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT xubin ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT linyuan ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT tangzeyao ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT jiangchunling ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats AT wangli ameliorativeeffectsofatractylodinonintestinalinflammationandcooccurringdysmotilityinbothconstipationanddiarrheaprominentrats |